INZYInozyme Pharma Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsMay 14
Mkt Cap$258.25M
Vol1.46M

About

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company was founded by Axel Bolte, Joseph P. Schlessinger, and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
67

Frequently Asked Questions

What is Market Cap of Inozyme Pharma Inc?
What is the 52-week high for Inozyme Pharma Inc?
What is the 52-week low for Inozyme Pharma Inc?
What is Inozyme Pharma Inc stock price today?
What was Inozyme Pharma Inc stock price yesterday?
What is the PE ratio of Inozyme Pharma Inc?
What is the Price-to-Book ratio of Inozyme Pharma Inc?
What is the 50-day moving average of Inozyme Pharma Inc?
How many employees does Inozyme Pharma Inc have?

Advertisement|Remove ads.